Posts In: Gubba Pharma In E News

Generic Drug Opportunities in Global Markets

May 26, 2021 Gubba Pharma In E News

Generic drugs have moved quickly over the last 30 years into a position of dominance in drug markets around the world. In 2018, generic drug...

Continue Reading

Bal Pharma launches anti-viral drug BALflu based on Favipiravir formula, priced at ₹85 per tablet

May 26, 2021 Gubba Pharma In E News

In its regulatory filing the company said, Favipiravir is an emerging anti viral drug used for patients with mild to moderate Covid-19 infection. This formulation...

Continue Reading

Tata, Godrej making storage units for Moderna, Pfizer COVID-19 vaccines

May 19, 2021 Gubba Pharma In E News

Tata-owned Voltas and Godrej Appliances are expanding their vaccine storage unit production and upgrading technology in order to accommodate the Pfizer and Moderna vaccines against...

Continue Reading

Bharat Biotech welcomes other pharma companies to manufacture Covaxin, but only one other Indian company has the required facility

May 19, 2021 Gubba Pharma In E News

Amid growing demand for waiving Intellectual Rights over Covid-19 vaccines and even granting compulsory licences to Pharmaceutical companies to manufacture the vaccines to tide over...

Continue Reading

Plasma therapy not effective, likely to be dropped from clinical management guidelines on Covid-19

May 19, 2021 Gubba Pharma In E News

Plasma therapy on Covid-19 patients has not been found effective in reducing the progression to severe disease or death and is likely to be dropped...

Continue Reading

India’s pharma market rebounds in April, clocks 51.5% sales growth

May 12, 2021 Gubba Pharma In E News

The domestic pharmaceuticals market has seen a rebound in April, with sales growing 51.5 per cent over last year, thanks to the low base of...

Continue Reading

Hyderabad’s Biological E set for Covid vaccine rollout by August

May 12, 2021 Gubba Pharma In E News

As the country grapples with the second wave of Covid-19, vaccine maker Biological E is gearing up to churn out 75 to 80 million doses...

Continue Reading

Roche India Gets Emergency Use Approval for Antibody Cocktail Used in Covid-19 treatment

May 12, 2021 Gubba Pharma In E News

Indian regulators have given emergency use authorization for an antibody-drug cocktail developed by Roche and Regeneron to treat COVID-19, Roche’s local partner said. The Central...

Continue Reading

Merck working closely with leading Indian Pharma giant to develop pill that can eliminate coronavirus

Amidst all the bad Covid news coming out of India there could be a glimmer of hope. As reported previously American Pharma major Merck has...

Continue Reading